Your Health, We Care

Home >Drug List>Quizartinib>Indications of Quizartinib

Quizartinib(Vanflyta)

Release date: 2026-01-05 15:28:09     Recommended: 44

Used for the treatment of relapsed or refractory FLT3-ITD mutation positive acute myeloid leukemia.